Evidence map›Paper›PMID 38221905›Full record

ArticleBriefings in bioinformatics2023

Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine model.

Ying Li, Jing Gao, Xubin Zheng, Guole Nie, Jican Qin, Haiping Wang, Tao He, Åsa Wheelock, Chuan-Xing Li, Lixin Cheng and 1 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Research progress on predictive models of portal vein thrombosis in liver cirrhosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Analysis of the genetic basis of fiber-related traits and flowering time in upland cotton using machine learning.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2025
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Ying LiThe First Hospital of Lanzhou University, Lanzhou, China.
Jing GaoRespiratory Medicine Unit, Department of Medicine & Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Xubin ZhengSchool of Computing and Information Technology, Great Bay University, Guangdong, China.
Guole NieThe First Hospital of Lanzhou University, Lanzhou, China.
Jican QinSchool of Computing and Information Technology, Great Bay University, Guangdong, China.
Haiping WangThe First Hospital of Lanzhou University, Lanzhou, China.
Tao HeJilin Hepato-Biliary Diseases Hospital, Changchun, China.
Åsa WheelockRespiratory Medicine Unit, Department of Medicine & Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Chuan-Xing LiRespiratory Medicine Unit, Department of Medicine & Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Lixin ChengShenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen, China.
Xun LiThe First Hospital of Lanzhou University, Lanzhou, China.
Lanzhou University · CNFirst Hospital of Lanzhou University · CNGreat Bay UniversityKarolinska Institutet · SEJinan University · CN

Funding

Clinical Research Center for General Surgery of Gansu Province 20JR10FA661National Natural Science Foundation of China 32300554National Natural Science Foundation of China 32370711Shenzhen Medical Research Fund A2303033Shenzhen Science and Technology Program JCYJ20220530152409020
6 · The paper itself

Abstract

backgroundPortal vein thrombosis (PVT) is a significant issue in cirrhotic patients, necessitating early detection. This study aims to develop a data-driven predictive model for PVT diagnosis in chronic hepatitis liver cirrhosis patients.

methodsWe employed data from a total of 816 chronic cirrhosis patients with PVT, divided into the Lanzhou cohort (n = 468) for training and the Jilin cohort (n = 348) for validation. This dataset encompassed a wide range of variables, including general characteristics, blood parameters, ultrasonography findings and cirrhosis grading. To build our predictive model, we employed a sophisticated stacking approach, which included Support Vector Machine (SVM), Naïve Bayes and Quadratic Discriminant Analysis (QDA).

resultsIn the Lanzhou cohort, SVM and Naïve Bayes classifiers effectively classified PVT cases from non-PVT cases, among the top features of which seven were shared: Portal Velocity (PV), Prothrombin Time (PT), Portal Vein Diameter (PVD), Prothrombin Time Activity (PTA), Activated Partial Thromboplastin Time (APTT), age and Child-Pugh score (CPS). The QDA model, trained based on the seven shared features on the Lanzhou cohort and validated on the Jilin cohort, demonstrated significant differentiation between PVT and non-PVT cases (AUROC = 0.73 and AUROC = 0.86, respectively). Subsequently, comparative analysis showed that our QDA model outperformed several other machine learning methods.

conclusionOur study presents a comprehensive data-driven model for PVT diagnosis in cirrhotic patients, enhancing clinical decision-making. The SVM-Naïve Bayes-QDA model offers a precise approach to managing PVT in this population.

Indexed as

Portal VeinVenous ThrombosisBayes TheoremFibrosisHumansLiver CirrhosisPrecision MedicineRisk Factorschronic cirrhosis patientsdata-driven precision medicine modeldiagnostic predictionmachine learningportal vein thrombosis

Identifiers

PMID38221905
PMCPMC10788706
OpenAlexW4390888939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.